In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy
Glycogen synthase kinase 3 beta (GSK3 β) plays a key role in pathologic hyper phosphorylation of tau and plays an important role in the pathogenesis of Alzheimer's disease. In the present study, we have screened a set of potential hits in in silico platform to gain insight regarding binding pro...
Saved in:
Main Authors: | Manisha Prajapat (Author), Phulen Sarma (Author), Nishant Shekhar (Author), Hardeep Kaur (Author), Sanjay Singh (Author), Subodh Kumar (Author), Harpinder Kaur (Author), Saniya Mahendiratta (Author), Amit Raj Sharma (Author), Sukhmandeep Kaur (Author), Vidya M Mahalmani (Author), Bikash Medhi (Author) |
---|---|
Format: | Book |
Published: |
Wolters Kluwer Medknow Publications,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Oral atenolol versus propranolol in the treatment of infantile hemangioma: A systematic review and meta-analysis
by: Swapnil Annasaheb Pattanshetti, et al.
Published: (2022) -
Molecular docking study of xylogranatins binding to glycogen synthase kinase-3β
by: Christian Bailly, et al.
Published: (2022) -
Development in Assay Methods for in Vitro Antimalarial Drug Efficacy Testing: A Systematic Review
by: Shweta Sinha, et al.
Published: (2017) -
In Silico Docking and Admet Prediction of a Novel Antibacterial Derivatives (Schiff Base) Targeting Dihydropteroate Synthase (1aj2)
by: Shubham N Karle, et al.
Published: (2024) -
A novel mutation in the glycogen synthase 2 gene in a child with glycogen storage disease type 0
by: Pereira Maria, et al.
Published: (2010)